Becker JC, Andersen MH, Hofmeister-Mueller V, Wobser M, Frey L, Sandig C, Walter S, Singh-Jasuja H, Kämpgen E, Opitz A, Zapatka M, Broecker EB, Straten PT, Schrama D, Ugurel S (2012)
Publication Status: Published
Publication Type: Journal article, Original article
Publication year: 2012
Book Volume: 61
Pages Range: 2091-2103
Journal Issue: 11
DOI: 10.1007/s00262-012-1266-9
APA:
Becker, J.C., Andersen, M.H., Hofmeister-Mueller, V., Wobser, M., Frey, L., Sandig, C.,... Ugurel, S. (2012). Survivin-specific T-cell reactivity correlates with tumor response and patient survival: A phase-II peptide vaccination trial in metastatic melanoma. Cancer Immunology, Immunotherapy, 61(11), 2091-2103. https://doi.org/10.1007/s00262-012-1266-9
MLA:
Becker, Juergen C., et al. "Survivin-specific T-cell reactivity correlates with tumor response and patient survival: A phase-II peptide vaccination trial in metastatic melanoma." Cancer Immunology, Immunotherapy 61.11 (2012): 2091-2103.
BibTeX: Download